Bill

Bill > HR4417


US HR4417

US HR4417
Capping Drug Costs for Seniors Act of 2021


summary

Introduced
07/13/2021
In Committee
07/13/2021
Crossed Over
Passed
Dead
01/03/2023

Introduced Session

117th Congress

Bill Summary

A BILL To amend title XVIII of the Social Security Act to provide for a cap on beneficiary liability under part D of the Medicare program, and for other purposes.

AI Summary

This bill aims to redesign the Medicare Part D prescription drug benefit by capping the maximum out-of-pocket costs for beneficiaries at $2,000 starting in 2022 and each subsequent year. It also establishes a new Manufacturer Discount Program, which will require drug manufacturers to provide discounted prices for certain prescription drugs to eligible Medicare beneficiaries at the point of sale. The bill also phases out the existing Medicare Coverage Gap Discount Program starting in 2022.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (3)

Last Action

Referred to the Subcommittee on Health. (on 07/13/2021)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...